Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Asensus Surgical Q4 EPS $(0.07) Beats $(0.08) Estimate, Sales $5.43M Beat $5.30M Estimate

Author: Benzinga Newsdesk | March 21, 2024 04:19pm
Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $5.43 million which beat the analyst consensus estimate of $5.30 million by 2.47 percent. This is a 120.41 percent increase over sales of $2.46 million the same period last year.

Posted In: ASXC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist